Group II (NRT, BATS) for Tobacco Dependence

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Tobacco Dependence+1 More
Nicotine Patch - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether two methods - behavioral activation therapy and nicotine replacement therapy - can help people quit smoking.

Eligible Conditions
  • Tobacco Dependence
  • Cigarette Smokers

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Tobacco Dependence

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Up to 4 months

Up to 4 months
Effectiveness of behavioral activation treatment for smoking plus nicotine replacement therapy versus standard cessation treatment plus nicotine replacement therapy defined as abstinence rate in low reward sensitivity- and + smokers
Mediators of the behavioral activation treatment for smoking plus nicotine replacement therapy treatment effect in low reward sensitivity- smokers

Trial Safety

Safety Progress

1 of 3

Other trials for Tobacco Dependence

Trial Design

2 Treatment Groups

Group II (NRT, BATS)
1 of 2
Group I (NRT, SC)
1 of 2
Active Control

85 Total Participants · 2 Treatment Groups

Primary Treatment: Group II (NRT, BATS) · No Placebo Group · N/A

Group II (NRT, BATS)ActiveComparator Group · 4 Interventions: Nicotine Patch, Behavioral Intervention, Laboratory Biomarker Analysis, Questionnaire Administration · Intervention Types: Drug, Behavioral, Other, Other
Group I (NRT, SC)ActiveComparator Group · 4 Interventions: Nicotine Patch, Laboratory Biomarker Analysis, Smoking Cessation Intervention, Questionnaire Administration · Intervention Types: Drug, Other, Behavioral, Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 4 months

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
12,989 Previous Clinical Trials
41,298,973 Total Patients Enrolled
10 Trials studying Tobacco Dependence
10,817 Patients Enrolled for Tobacco Dependence
M.D. Anderson Cancer CenterLead Sponsor
2,779 Previous Clinical Trials
1,784,934 Total Patients Enrolled
1 Trials studying Tobacco Dependence
839 Patients Enrolled for Tobacco Dependence
Jennifer A MinnixPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
24 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 26th, 2021

Last Reviewed: October 29th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.